topterone

(17β)-17-Hydroxy-17-propylandrost-4-en-3-one

(8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-17-propyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-on

(8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-17-propyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one

(8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-diméthyl-17-propyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tétradécahydro-3H-cyclopenta[a]phénanthrén-3-one

(8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-17-propyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name)

17b-Hydroxy-17-propylandrost-4-en-3-one

17β-Hydroxy-17-propylandrost-4-en-3-one

262-321-4

60607-35-4

77WPB17ZK1

Androst-4-en-3-one, 17-hydroxy-17-propyl-, (17β)-

topterone

(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-17-propyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one